Healthcare, Pharmaceuticals and Biotech

Kroll helps organizations in the healthcare, pharmaceuticals and biotechnology sectors address complex business challenges related to governance, risk and transparency.

Pharmaceutical, healthcare, biotech and medical device companies face a challenging, competitive health landscape. Pricing pressures, scientific breakthroughs, expanding demand for healthcare access and emerging digital and analytic capabilities push companies to explore unconventional business models and build value-based customer relationships.

Underpinning these dynamics is the uncertainty created by a post-COVID-19 environment. The implications have been far-reaching and will likely impact the entire life science ecosystem. While companies need to be aware of the risks to their organization, Kroll understands the complexity of these challenges and works with clients worldwide to drive progress, navigate new opportunities and manage risk.

Our life sciences specialists bring practical, in-depth experience to healthcare and life sciences companies, including consumer health, medical devices, diagnostics and pharmaceuticals. We help our clients address their most pressing challenges in in the areas of valuation, expert services, investigations, cyber risk, corporate finance, security, restructuring, legal and business solutions, data analytics, due diligence and regulatory compliance.

Kroll recently spoke with intellectual property expert Alexandra Pygall, a partner at Stephenson Harwood LLP, on patent waivers for the COVID-19 vaccines. Watch this short video to learn more about how patent waivers play a role in the global distribution of vaccines and what it can mean for the future of the healthcare and pharmaceutical industries.

Kroll Life Sciences Webcast Series

Life Sciences Week Webcast: Navigating the Elevated Risk Environment

Pharmaceutical, healthcare, biotech and medical device companies face a challenging, competitive health landscape. Pricing pressures, scientific breakthroughs, expanding demand for healthcare access and emerging digital and analytic capabilities push companies to explore unconventional business models and build value-based customer relationships. Kroll recently brought together our leading experts and industry leaders to share insights and trends on valuation, technology, intellectual property (IP), risk and regulation in a life sciences webcast series.


Watch Webcast Replay

 

Life Sciences Week Webcast: Navigating the Elevated Risk Environment

Connect With Us

Andreas Chrysostomou
Andreas Chrysostomou
Managing Director
Valuation Advisory Services
New York
Phone
Brooks Dexter
Brooks Dexter
Senior Advisor
Healthcare Investment Banking
Los Angeles
Phone
Nick Beaton
Nick Beaton
Associate Managing Director
Compliance Risk and Diligence
London
Phone
Tom Everett Heath
Tom Everett Heath
Global Head of Forensic Investigations and Intelligence
Forensic Investigations and Intelligence
London
Phone
Jason N Smolanoff
Jason N. Smolanoff
President, Cyber Risk
Cyber Risk
Los Angeles
Phone
Nicholas Doyle
Nick Doyle
Managing Director and Regional Leader, EMEA and APAC
Security Risk Management
London
Phone

See all servicesStay Ahead with Kroll

Valuation

Valuation

Valuation of businesses, assets and alternative investments for financial reporting, tax and other purposes.

Cyber Risk

Cyber Risk

Incident response, digital forensics, breach notification, managed detection services, penetration testing, cyber assessments and advisory.

Compliance and Regulation

Compliance and Regulation

End-to-end governance, advisory and monitorship solutions to detect, mitigate and remediate security, legal, compliance and regulatory risk.

Corporate Finance and Restructuring

Corporate Finance and Restructuring

M&A advisory, restructuring and insolvency, debt advisory, strategic alternatives, transaction diligence and independent financial opinions.

Investigations and Disputes

Investigations and Disputes

World-wide expert services and tech-enabled advisory through all stages of diligence, forensic investigation, litigation, disputes and testimony.

Digital Technology Solutions

Digital Technology Solutions

Enriching our professional services, our integrated software platform helps clients discover, quantify and manage risk in the corporate and private capital market ecosystem.

Business Services

Business Services

Expert provider of complex administrative solutions for capital events globally. Our services include claims and noticing administration, debt restructuring and liability management services, agency and trustee services and more.

Environmental, Social and Governance

Environmental, Social and Governance

Advisory and technology solutions, including policies and procedures, screening and due diligence, disclosures and reporting and investigations, value creation, and monitoring.

European Chemicals Update Report – Spring 2023
M&A Updates

European Chemicals Update Report – Spring 2023

Jun 05, 2023

by Andreas StoecklinPhilipp BoseJavier ZoidoJacques GiardDavid AlthoffStephen BurtDavid LuKatsumi  Asai Howard JohnsonAlexandre PierantoniPaul TeutenDafydd Evans

Fraud and Financial Crime Report 2023 Breakfast Briefing
Financial Crime

Fraud and Financial Crime Report 2023 Breakfast Briefing

Jul 05, 2023 - Join us for a breakfast discussion, led by our financial crime experts who will dive into the Fraud and Financial Crime Report 2023 survey insights and explore the tools and strategies you need to stay compliant and minimize your risk.

Kroll at Infosecurity Europe 2023
Digital Forensics and Incident Response

Kroll at Infosecurity Europe 2023

Jun 20, 2023 - Join Kroll cyber risk experts at Infosecurity Europe in London June 20-22. Stop by stand R70 to catch the latest trends from the cyber frontlines.

Return to top